Background. Postmastectomy breast reconstruction is an important component of breast cancer care, but few receive it at the time of the mastectomy. Virtually nothing is known about receipt of reconstruction after initial cancer therapy and why treatment might be delayed. Materials and Methods. A 5-year follow-up survey was mailed to a population-based cohort of mastectomy-treated breast cancer patients who were initially surveyed at time of diagnosis in 2002 and reported to the Los Angeles and Detroit SEER registries (N = 645, response rate 60%). Outcomes were receipt of reconstruction (immediate [IR], delayed [DR], or none) and patient appraisal of their treatment decisions. Results. About one-third (35.9%) had IR, 11.5% had DR, and 52.6% had no reconstruction. One-third delayed reconstruction because they focused more on other cancer interventions, and nearly half were concerned about surgical complications and interference with cancer surveillance. Two-thirds of those with no reconstruction said that the procedure was not important to them. A large proportion of all patients were satisfied with their reconstruction decision-making (89.4% IR, 78.4% DR, 80.4% no reconstruction, P = NS). However, only 59.3% of those with no reconstruction felt that they were adequately informed about their reconstructive options (vs 82.7% IR and 78.4% DR, P \ .01).
said that the procedure was not important to them. A large proportion of all patients were satisfied with their reconstruction decision-making (89.4% IR, 78.4% DR, 80.4% no reconstruction, P = NS). However, only 59.3% of those with no reconstruction felt that they were adequately informed about their reconstructive options (vs 82.7% IR and 78.4% DR, P \ .01).
Conclusions. There was modest uptake of breast reconstruction after initial cancer treatment. Factors associated with delayed reconstruction were primarily related to uncertainty about the procedure, concern about cancer surveillance, and low priority. Those without reconstruction demonstrated significant informational needs, which should be addressed with future research efforts.
Postmastectomy breast reconstruction is an important option for women with breast cancer. 1 Current evidence suggests that the use of postmastectomy breast reconstruction at the time of the mastectomy (i.e., immediate reconstruction) is low, with national estimates around 16%. 2, 3 In addition, significant disparities exist in the receipt of immediate breast reconstruction by patient race/ ethnicity and sociodemographic factors. 2, 4, 5 Limited knowledge, financial barriers, and inadequate referrals to reconstructive surgeons have contributed to the low use of immediate breast reconstruction for minority patients. [4] [5] [6] The extent to which these disparities persist in the survivorship period is unclear.
Women who initially receive mastectomy without reconstruction may revisit this decision later. Yet, virtually nothing is known about the decision-making process for patients as they cope with the impact of their surgery on
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their body image, self-esteem, and sexuality. Although there are clinical reasons to delay reconstruction, such as the need for adjuvant radiation therapy, there is virtually no information regarding the quality of life factors that motivate the decision for reconstruction and whether these factors differ by the timing of reconstruction. 7 The impact of the timing of reconstruction on patients' satisfaction with their surgical decision is also poorly understood. Previous studies suggest that women who received immediate reconstruction were significantly more satisfied with their surgical treatment decision compared with those who had a mastectomy only, but the relationship between decision delay and patient appraisal of the decision process has not been well studied. 5 To address these issues, we performed a 5-year followup survey to a population-based cohort of breast cancer patients and evaluated receipt of immediate and delayed postmastectomy breast reconstruction. The research objectives were: (1) to describe the proportion of mastectomy-treated patients who undergo delayed breast reconstruction; (2) to evaluate the underlying factors that contribute to the decision to receive immediate, delayed, or no breast reconstruction; and (3) to assess the association between receipt of immediate, delayed, or no breast reconstruction with patients' satisfaction with their surgical decision.
METHODS

Population Sample and Data Collection
Eligible patients were women age B79 years with ductal carcinoma in situ (DCIS) or invasive breast cancer diagnosed and reported to the Surveillance, Epidemiology, and End Results (SEER) registries of the greater metropolitan areas of Detroit and Los Angeles during a 14-month period between December 2001 and January 2003. We have previously reported the population sampling and data collection from the initial survey performed at the time of diagnosis. 4 Eligible patients underwent a definitive surgical procedure, resided in the SEER catchment area, and were able to complete a questionnaire in English or Spanish. We prospectively selected all patients meeting the study criteria and oversampled African Americans (N = 2647). Approximately 90% of all patients identified were eligible for the study (N = 2382). A self-administered survey was completed about 9 months after diagnosis by 77.4% of eligible patients.
The sample selected for this follow-up study included the 638 respondents (298 Detroit and 340 Los Angeles patients) who underwent a mastectomy. An introductory letter, questionnaire, and gift worth $10 were mailed between July 2007 and November 2008. The Dillman survey method was used to encourage response. 8 The survey was completed by 384 patients (response rate 60.2%). Compared with survey respondents, nonrespondents had a significantly higher proportion of blacks (30% vs. 20%, respectively, P = .038), lower incomes (P \ .001), less education (P \ .001), lower proportion of stage 0 disease (25% vs. 37%, P \ .001), but did not differ significantly by age. The study protocol was approved by the Institutional Review Boards of the University of Michigan, the University of Southern California, and Wayne State University.
Measures
The patient questionnaire was developed based on a conceptual model, extensive pilot testing, and prior work by our team surveying breast cancer patients. 4, 9, 10 Use of Reconstruction The primary dependent variable, receipt of reconstruction following mastectomy, had 3 categories: the patient received reconstruction at the same time as the mastectomy (immediate reconstruction), received reconstruction at any point after the mastectomy but before completion of the survey (delayed reconstruction), or did not receive reconstruction at the time of the follow-up survey (no reconstruction). For delayed reconstruction, the time from mastectomy to reconstruction was recorded in months.
Factors Associated with the Reconstruction Decision We described 3 general psychosocial factors that we hypothesized would be associated with the decision for reconstruction: body image, pragmatic concerns, and sexuality (see Fig. 2 for specific questions). A 5-point Likert scale was used to measure responses, which ranged from strongly disagree to strongly agree, and dichotomized into low and moderate (B3) or high (4-5) for analytical purposes. Applying different categorizations did not significantly alter the results.
We also evaluated 4 general reasons why patients delayed breast reconstruction or did not receive reconstruction: patient-reported physician concerns, patient concerns about reconstruction outcomes, patient treatment priorities, and access barriers to reconstruction (see Table 2 for specific questions). The items evaluating patientreported physician concerns, patient priorities, and access barriers were measured on 5-point Likert scales (not at all to extremely concerned), which were dichotomized into low and moderate (B3) or high (4-5) for analytical purposes. For patient concerns about reconstruction, respondents could check multiple items from a list of options.
Decision Satisfaction To evaluate patients' degree of satisfaction with their decision for immediate, delayed or no reconstruction, we used multiple items (described in Table 3 ) from Holmes-Rovner's decisional satisfaction scale and the O'Connor decisional regret scale. [11] [12] [13] The 5-point Likert responses (low to high) were dichotomized into low and moderate (B3) or high (4-5) for analytical purposes.
Control Variables
The independent variables included (1) patient sociodemographic characteristics (age, race, marital status, income, insurance status, and education) and (2) patients' clinical factors (presence of comorbid conditions, AJCC Stage, receipt of chemotherapy, and receipt of radiation therapy). Age was self-reported and analyzed as a continuous variable. Race was categorized as white, black, or other. Marital/domestic partner status was determined by whether the patient was living with a spouse or partner at the time of cancer diagnosis (yes/no). Income was grouped as (1) \$30,000, (2) $30,000-69,999, (3) C$70,000, and (4) missing. Insurance status was grouped as private insurance/other, Medicaid/Medi-Cal, Medicare, and none. Education was collapsed into a 3-level categorical variable: high school graduate or less, some college, and college graduate. Patient body-mass index was described as \25, 25-30, and [30. The number of comorbidities was obtained from the patient survey from a list of 7 common medical comorbidities and subsequently collapsed into a 2-level variable (0 or C1). The summary cancer stage was obtained from SEER and was classified using the AJCC staging system for breast carcinoma (DCIS (stage 0) or invasive carcinoma of stages 1-3).
14 Receipt of chemotherapy and radiation therapy were both analyzed as 2-level categorical variables (yes/no).
Analyses
We first described receipt of breast reconstruction (immediate, delayed, and no reconstruction) across all sociodemographic and clinical factors. We described the cumulative proportion of patients who underwent delayed breast reconstruction after the mastectomy. Pearson chisquare was used for the bivariate analyses between outcomes and categorical independent variables, and the t test was used for continuous variables.
Next we described factors underlying breast reconstruction decisions, such as body image and sexuality concerns, by receipt of immediate, delayed reconstruction, or no reconstruction. We also described patient-reported reasons for delaying the decision for reconstruction or choosing not to have reconstruction that were related to patient priorities and barriers. Pearson chi-square was used to compare differences in response by receipt of reconstruction.
Last, we evaluated patients' satisfaction and regret with the breast reconstruction decision according to whether the patient received immediate, delayed, or reconstruction. Pearson chi-square was used to compare differences in decisional outcomes by receipt of reconstruction. Values were adjusted for age, stage, education, and race using logistic regression. All analyses were performed with STATA version 8.0.
RESULTS
Use of Reconstruction
Of the 384 mastectomy-treated breast cancer patients in the study, 138 (35.9%) received immediate reconstruction, 44 (11.5%) received delayed reconstruction, and 202 (52.6%) did not receive reconstruction. Figure 1 shows that mean time to delayed reconstruction was 21.6 months, and all of the sample patients who received reconstruction did so by 4.5 years postmastectomy.
We observed few significant differences in the sociodemographic characteristics between those who received immediate and delayed breast reconstruction ( Table 1) . Most of the statistically significant findings reflected differences between those with reconstruction (immediate or delayed) and those without reconstruction. For example, patients who did not receive reconstruction compared with those with immediate or delayed reconstruction were significantly older (67 vs. 57 years and 58 years, respectively, P \ .001) and were significantly more likely to be African American (29% vs. 12% and 18%, respectively, P \ .001). One-third of patients without reconstruction were in the lowest income group compared with only 12% of those with immediate reconstruction and 14% of those with delayed procedures (P \ .001).
Women who received immediate breast reconstruction did differ from those who received delayed or no reconstruction by several clinical factors. Women who underwent immediate reconstruction compared with those with delayed or no reconstruction were significantly more likely to have had DCIS (51% vs. 35% and 30%, respectively, P for stage \.001) and significantly less likely to have received chemotherapy or radiation therapy (chemotherapy: 23% vs. 44% and 32%, respectively, P = .036; radiation therapy: 10% vs. 30% and 25%, respectively, P = .002). Of note, receipt of reconstruction did not vary significantly by patient body-mass index.
Factors Associated with the Reconstruction Decision
Most of the differences in factors associated with the reconstruction decision (body image and pragmatic concerns) were found between those with reconstruction (immediate or delayed) and those without reconstruction (Fig. 2) . For example, a higher proportion of women with immediate and delayed reconstruction compared with those without reconstruction expressed that their decision about reconstruction was motivated by body image concerns (90% and 98% vs. 71%, respectively, wanted to feel whole again, P \ .001) and pragmatic reasons (97% and 100% vs. 72%, respectively, wanted to avoid wearing a prosthesis, P \ .001). However, women who received immediate reconstruction compared with those with delayed or no reconstruction appeared significantly more motivated to have surgery for sexuality reasons (94% vs. 81% and 74%, respectively, reported wanting to feel less self-conscious during sexual activity, P \ .001).
We found very few patients who had delayed or no reconstruction report that their physician expressed concern about reconstruction; however, a large proportion of patients had concerns about the outcomes of reconstruction (Table 2) . For example, patients who received delayed or no reconstruction were concerned about surgical complications (48.8% and 60.3%) and interference with the detection of cancer recurrence (48.8% and 60.5%), respectively. Those with no reconstruction compared with those who received delayed reconstruction expressed significantly more concern regarding the length of postoperative recovery (59.4% vs. 41.9%, respectively, P = .04) and the long-term health problems related to reconstruction (59.5% vs. 41.9%, respectively, P = .038). Patients from both groups expressed a low priority for breast reconstruction compared with other cancer treatments. Approximately one-third of those who received delayed reconstruction and almost half of those with no reconstruction reported that they did not pursue reconstruction at the time of the mastectomy because they were focused on treating the cancer. Patients without reconstruction compared with those who received delayed breast reconstruction were more likely to express that reconstruction was a low priority: 63.4% vs. 11.4% said reconstruction was not important to them, respectively, P \ .001, and 63.4% vs. 18.2% said that they did not want more surgery, respectively, P \ .001. Very few patients reported an access barrier to reconstruction.
Decision Satisfaction
Overall, a high proportion of patients with immediate, delayed, and no reconstruction were satisfied with their decision about breast reconstruction (89%, 78%, and 80%, respectively, P = NS) (Table 3) . However, those who received immediate breast reconstruction were less likely to regret the choice about whether or not to have reconstruction compared with those with delayed or no reconstruction (7% vs. 24% and 17%, respectively, P = .054), and those who had no breast reconstruction were significantly less likely to feel that they were adequately informed about the decision compared with those with immediate and delayed reconstruction (59% vs. 83% and 78%, respectively, P = .002).
DISCUSSION
This is one of the first studies to describe the use of delayed breast reconstruction using a population-based sample of breast cancer patients. We found modest uptake of breast reconstruction after initial cancer therapy: 12% had delayed reconstruction, about one-third had immediate reconstruction, and about half of patients ultimately did not receive reconstruction. Factors associated with delayed reconstruction were primarily related to uncertainty about the procedure, concern about cancer surveillance, and low priority. This is also one of the first studies to our knowledge to evaluate differences in sociodemographic and motivating factors among women receiving reconstruction at different time points and women choosing not to undergo reconstruction. We found some significant differences between these 3 groups according to sociodemographic and motivating factors. Women without reconstruction tended to be more socioeconomically Breast reconstruction is a treatment decision that can be revisited over time. Ensuring patient access to breast reconstruction in both the immediate and delayed setting has important implications for women's quality of life in the survivorship period. [15] [16] [17] [18] [19] In our study, about half of women who received delayed breast reconstruction did so within the first year after mastectomy. This suggests a high demand for the procedure by these patients, but they may not have been adequately informed or encouraged to consider reconstruction at the time of the mastectomy. Furthermore, many of the clinical contraindications for immediate breast reconstruction do not persist in the survivorship period, therefore allowing uptake of delayed reconstruction for those with more advanced disease. 7, [20] [21] [22] [23] However, it appears that some of the socioeconomic disparities associated with receipt of immediate reconstruction persist after initial cancer treatment. 2, 5 The association between patient socioeconomic status and surgical breast cancer care has been well documented over the past 15 years. [24] [25] [26] [27] [28] [29] [30] [31] Socioeconomically disadvantaged patients are less likely to be counseled by the general surgeon about reconstructive options, and now appear to be less likely to receive breast reconstruction in the immediate and delayed treatment setting. 32 Our study suggests that 3 primary factors drive the decision to delay or not have breast reconstruction. For many, breast reconstruction is a low priority. One-third of those with delayed reconstruction and nearly half of those with no reconstruction were focused on treating the cancer and therefore did not undergo immediate breast reconstruction. Breast reconstruction continued to be a low priority in the survivorship period for almost two-thirds of women who never received it. Many patients also expressed uncertainty about the reconstructive procedure. Nearly half of those who delayed and 60% of those who did not receive reconstruction were concerned about the possible complications of reconstruction and concerned that reconstruction would interfere with cancer surveillance. While a detailed discussion of the complications associated with reconstruction is the domain of the plastic surgeon, general surgeons treating breast cancer patients should be able to reassure them that performance of reconstruction does not impact the risk of cancer recurrence or its detection. In addition, patients who did not receive reconstruction were significantly less informed about reconstruction compared with those who received it.
The unmet information needs about reconstruction found in this study are supported by our previous work that focused on African American and Latina breast cancer patients. 5 Minority patients compared with whites are significantly less likely to see a plastic surgeon prior to the mastectomy and are significantly more likely to desire additional information about reconstruction. 5 However, our previous work suggests that meeting with a plastic surgeon prior to surgical treatment lessens concern about reconstruction and significantly motivates patients to consider reconstruction as a treatment priority. 32 
Limitations
These results are limited to 2 metropolitan areas, Detroit and Los Angeles, and may not reflect national trends in breast cancer care. However, the large racial/ethnic diversity of this population-based study and the high response rate suggest that we have a sample that is well representative of breast cancer patients in the United States. We were also limited by the self-reported nature of our variables, which may be subject to recall bias. However, we expect that women's report of receipt of reconstruction is highly accurate. The modest response rate to the follow-up survey may have introduced response bias. Nonresponders were significantly more socioeconomically disadvantaged, which may have attenuated associations between socioeconomic status and receipt of delayed reconstruction.
Policy Implications
Our findings have important implications for breast cancer care and policy. The strong educational gradients in receipt of reconstruction, the unmet information needs, and the decisional uncertainty about reconstruction outcomes motivate an initiative to improve the decision-making process at the time of cancer diagnosis. The American Society of Plastic Surgeons has recognized the importance of education and has initiated a campaign called ''Choices'' aimed at informing breast cancer patients of their reconstructive options and promoting multidisciplinary breast cancer care that includes access to plastic surgeons. 33 Another approach is to develop and deploy decision tools that general surgeons can use at the time of cancer diagnosis and oncologists and internists can use in the survivorship period to educate patients about the risks and benefits of reconstructive surgery. Decision tools are wellestablished techniques associated with improved decisional quality for breast cancer care. 34 
